Bronchiolitis Obliterans (BO) Terminated Phase 2 Trials for Budesonide (DB01222)

Also known as: Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome (BOS) / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0116742 (Bronchiolitis Obliterans (BO))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01432080Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post AllotransplantPrevention